Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORTX | AMGN | VRTX | GILD | BMY |
| Company | Orchard Therapeutics Plc ADR | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 16.65 | 262.18 | 403.14 | 92.62 | 56.93 |
| High | 16.72 | 263.58 | 409.60 | 92.83 | 57.38 |
| Low | 16.63 | 259.24 | 402.72 | 91.53 | 56.73 |
| Last | 16.70 | 259.37 | 403.50 | 91.57 | 56.79 |
| Change | +0.05 | -1.27 | +0.80 | -0.80 | +0.23 |
| % Change | +0.30% | -0.49% | +0.20% | -0.87% | +0.41% |
| Volume | 372,300 | 1,004,879 | 621,920 | 1,279,270 | 4,354,921 |
| 20-Day Average Volume | 130,995 | 3,687,287 | 1,853,056 | 6,681,595 | 11,013,573 |
| Previous Close | 16.65 | 260.64 | 402.70 | 92.37 | 56.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.47 | 267.32 | 437.20 | 92.39 | 57.33 |
| 20-Day Raw Stochastic | 94.20% | 24.16% | 27.45% | 47.27% | 38.24% |
| 20-Day Relative Strength | 84.63% | 31.68% | 35.03% | 51.05% | 50.32% |
| Weighted Alpha | +90.00 | -19.34 | -10.19 | +19.35 | +16.22 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Sell | 88% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 72% Sell | 88% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.58% since 01/16/24 | -1.79% since 12/24/24 | -0.80% since 12/24/24 | -2.34% since 12/24/24 | -1.58% since 12/24/24 |
| Low | 16.39 on 01/17/24 | 258.50 on 12/30/24 | 399.06 on 12/30/24 | 91.53 on 01/02/25 | 55.93 on 12/31/24 |
| High | 16.72 on 01/23/24 | 264.73 on 12/26/24 | 411.29 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 |
| 1-Month | |||||
| %Chg | +1.71% since 12/22/23 | -6.60% since 12/02/24 | -13.06% since 12/02/24 | -2.41% since 12/02/24 | -5.16% since 12/02/24 |
| Low | 16.38 on 01/03/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 16.72 on 01/23/24 | 281.38 on 12/03/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | +4.51% since 10/23/23 | -18.76% since 10/02/24 | -12.38% since 10/02/24 | +8.27% since 10/02/24 | +5.74% since 10/02/24 |
| Low | 15.78 on 10/31/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 |
| High | 16.72 on 01/23/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +215.69% since 07/21/23 | -16.42% since 07/02/24 | -14.53% since 07/02/24 | +34.14% since 07/02/24 | +40.53% since 07/02/24 |
| Low | 4.80 on 09/11/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 16.72 on 01/23/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 380,109 | 140,102,608 | 103,706,928 | 115,117,592 | 114,713,688 |
| Shares Outstanding, K | 22,761 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 22,660,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -150,660,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 6,300,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -35,320,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.55 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/13/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 03/04/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 0.00 | 20.77 | 47.91 |